Adamas Pharmaceuticals reported 126.16M in Loan Capital for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Aerie Pharmaceuticals AERI:US $ 222.02M 5.94M
Aptinyx Inc APTX:US $ 0 0
Biocryst Pharmaceuticals BCRX:US $ 263.66M 9.32M
Flexion Therapeutics FLXN:US $ 220.02M 14.99M
GlaxoSmithKline GSK:LN 20442M 2605M
Glaxosmithkline GSK:US $ 20442M 2605M
Gw Pharmaceuticals GWPH:US $ 14.16M 0.14M
Heron Therapeutics HRTX:US $ 148.98M 148.98M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 10.97M 10.97M
Neurocrine Biosciences NBIX:US $ 326.3M 4.3M
Novartis NOVN:VX SF 26491M 908M
Omeros OMER:US $ 312.58M 426K
Prothena PRTA:US 0 0
Revance Therapeutics RVNC:US $ 280M 0.31M
Teva Pharmaceutical TEVA:IT 21.6B 686M
Zogenix ZGNX:US $ 153.63M 2.18M